Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Raw Materials (2024)

Whitehawk Therapeutics (WHWK) has disclosed Raw Materials for 1 consecutive years, with $3.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Raw Materials changed N/A to $3.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $3.5 million, a N/A change, with the full-year FY2024 number at $3.5 million, changed N/A from a year prior.
  • Raw Materials was $3.5 million for Q4 2024 at Whitehawk Therapeutics.
  • In the past five years, Raw Materials ranged from a high of $3.5 million in Q4 2024 to a low of $3.5 million in Q4 2024.